Pages that link to "Q54558451"

The following pages link to A general strategy for the expression of recombinant human cytochrome P450s in Escherichia coli using bacterial signal peptides: expression of CYP3A4, CYP2A6, and CYP2E1. (Q54558451):

Displaying 40 items.

• Crystal structure of human cytochrome P450 2D6 (Q24298673) (← links)
• Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3. (Q31148688) (← links)
• Strategies to enhance the coexpression of cytochrome P450 2E1 and reductase in bacteria (Q33538232) (← links)
• Merits and limitations of recombinant models for the study of human P450-mediated drug metabolism and toxicity: an intralaboratory comparison. (Q33639797) (← links)
• Expression and secretion of proteins in E. coli. (Q33770572) (← links)
• Recombinant in vitro tools to predict drug metabolism and safety (Q33856594) (← links)
• Heterologous expression of xenobiotic mammalian-metabolizing enzymes in mutagenicity tester bacteria: an update and practical considerations (Q33942241) (← links)
• Autoantigen characterization in liver/kidney microsome positive hepatitis (Q34024689) (← links)
• Engineering of a functional human NADH-dependent cytochrome P450 system (Q34583746) (← links)
• Allelic Variation of Cytochrome P450s Drives Resistance to Bednet Insecticides in a Major Malaria Vector (Q35827110) (← links)
• An expression tag toolbox for microbial production of membrane bound plant cytochromes P450. (Q36164921) (← links)
• The cytochrome P450 CYP6P4 is responsible for the high pyrethroid resistance in knockdown resistance-free Anopheles arabiensis. (Q36474711) (← links)
• The influence of microbial physiology on biocatalyst activity and efficiency in the terminal hydroxylation of n-octane using Escherichia coli expressing the alkane hydroxylase, CYP153A6. (Q36686957) (← links)
• Bioactivation and Regioselectivity of Pig Cytochrome P450 3A29 towards Aflatoxin B₁. (Q37285690) (← links)
• A role for cytochrome b5 in the In vivo disposition of anticancer and cytochrome P450 probe drugs in mice (Q37604428) (← links)
• Enhancing full-length antibody production by signal peptide engineering (Q38749177) (← links)
• Induced thiacloprid insensitivity in honeybees (Apis mellifera L.) is associated with up-regulation of detoxification genes (Q38870729) (← links)
• De-bugging and maximizing plant cytochrome P450 production in Escherichia coli with C-terminal GFP fusions. (Q38958683) (← links)
• Export of cytochrome P450 105D1 to the periplasmic space of Escherichia coli (Q39490816) (← links)
• Use of transgenic cell lines in mechanistic studies of drug metabolism (Q40803367) (← links)
• Determinants of the substrate specificity of human cytochrome P-450 CYP2D6: design and construction of a mutant with testosterone hydroxylase activity (Q41806994) (← links)
• Defining the in Vivo Role for cytochrome b5 in cytochrome P450 function through the conditional hepatic deletion of microsomal cytochrome b5. (Q41824446) (← links)
• Phe120 contributes to the regiospecificity of cytochrome P450 2D6: mutation leads to the formation of a novel dextromethorphan metabolite. (Q42103895) (← links)
• In vitro effects of active constituents and extracts of Orthosiphon stamineus on the activities of three major human cDNA-expressed cytochrome P450 enzymes (Q42753981) (← links)
• Kinetics of electron transfer between NADPH-cytochrome P450 reductase and cytochrome P450 3A4. (Q42873685) (← links)
• Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent. (Q43597583) (← links)
• The toxicity of styrene to the nasal epithelium of mice and rats: studies on the mode of action and relevance to humans (Q43733645) (← links)
• In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids (Q43960740) (← links)
• Characterization of inhibitors and substrates of Anopheles gambiae CYP6Z2. (Q44140603) (← links)
• Characterization of mixtures of recombinant human cytochrome p450s as a screening model for metabolic stability in drug discovery (Q44191382) (← links)
• Residues glutamate 216 and aspartate 301 are key determinants of substrate specificity and product regioselectivity in cytochrome P450 2D6. (Q44226094) (← links)
• An amperometric biosensor with human CYP3A4 as a novel drug screening tool (Q44461918) (← links)
• In vitro metabolism of genistein and tangeretin by human and murine cytochrome P450s (Q44492695) (← links)
• Membrane integration of recombinant human P450 forms. (Q45965531) (← links)
• Cytochrome P450 reductase from Candida apicola: versatile redox partner for bacterial P450s (Q48050324) (← links)
• Recombinant Production of Eukaryotic Cytochrome P450s in microbial cell factories (Q50048298) (← links)
• Pyrethroid Resistance in the Major Malaria Vector Anopheles funestus is Exacerbated by Overexpression and Overactivity of the P450 CYP6AA1 Across Africa. (Q52879058) (← links)
• Comparison of microbial hosts and expression systems for mammalian CYP1A1 catalysis (Q84814871) (← links)
• An amperometric biosensor based on rat cytochrome p450 1A1 for benzo[a]pyrene determination (Q85195994) (← links)
• De novo production of benzyl glucosinolate in Escherichia coli (Q92112273) (← links)